Global Radiotherapy Market -Industry Trends and Forecast to 2024
The increased demand for Radiotherapy Industry has motivated much prominent in terms of
Value, Demand, Analysis around the world. The Global Radiotherapy Market will almost
double by 2024 from its current market value.
Global Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT,
Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic
Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic
Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By
Geography (North America, Europe, Asia Pacific, South America, Rest of the World) –
Industry Trends and Forecast to 2024
Exclusive Sample Report @
https://www.reportsworldwide.com/enquiry?report_id=4577
Global Radiotherapy Market is expected to reach USD 5.3 billion by 2024, at a CAGR of
7.5% in the forecast period 2017 to 2024.
The report contains 276 pages of exclusive premium insights with 284 tables and
56 figures.
Cancer is the major cause of death in the world and the number of new patients each year
is steadily increasing. The most common form of cancer mortality is by metastasis, where
the tumours and cancerous cells spread to organs causing failure. The world is focused upon
developing solutions and cure to cancer by destroying primary and secondary tumours that
cause metastasis. In current healthcare scenario localized treatment of tumours the only
efficient treatment for tumours. Radiosurgery is used alongside surgery or separately to
treat cancer for a long time. More than 75% of the cancer patient population is expected to
take radiosurgery in some point of their disease prognosis.
The global radiotherapy market is segmented based on therapy, the market is segmented
into external beam radiotherapy, internal beam radiotherapy, and systemic radiation
therapy.
Based on product type the global radiotherapy market is segmented into EBRT equipment’s,
and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further
segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The
Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
The global radiotherapy market is also segmented based on indication into cancer of
different organs such as brain tumour, spine cancer, lung cancer, liver cancer, breast
cancer, prostate cancer and others.
Based on mode of administration the market is segmented into skin, circulatory, organs and
central nervous system.
The global radiotherapy market is segmented into 5 geographical regions, North America,
Europe, Asia-Pacific, South America and rest of the world. These regions are further
classified on the basis of country, into 24 major countries such as U.S. Canada, Mexico,
Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore,
Brazil, India, Russia, South Africa and many others.